U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to ...

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over ...

Enabling Rapid Growth: Medicilon's integrated platform for drug discovery, pharmaceutical research, and preclinical development will expedite the regulatory pathways for Oncotelic's and SAPU's ...

Ribonucleic acid, commonly known as RNA, is involved in many biological functions, and some, including gene silencing, are utilized to cure diseases. RNA has recently gained attention as a promising ...

Oncology, titled "Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention," a research team from Guangzhou ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be ...

Avidity Biosciences specializes in RNA-based therapies using Antibody-oligonucleotide conjugates to deliver drugs directly to ...

Strong evidence for ALS often comes from familial forms of the disease, where specific gene mutations— for example in the ...

Famed chip maker and hardware giant Nvidia has been investing significant resources into the healthcare and life sciences ...